-
Crisaborole
Lebitso la API Pontsho Moqapi Letsatsi la Phello ea Patent(US) Crisaborole Dermatitis ea Atopic le Eczema Pfizer -
Etelcacetide
Lebitso la API Pontsho Moqapi Letsatsi la Phello ea Patent(US) Etelcacetide Hyperparathyroidism ea bobeli (HPT) Amgen -
Abemaciclib
Lebitso la API Pontsho Moqapi Letsatsi la Phello ea Patent(US) Abemaciclib Kankere ea matsoele, phekolo ea kankere ea senya Eli Lily Dec.15,2029 -
Deucracitinib
Lebitso la API Pontsho Moqapi Letsatsi la Phello ea Patent(US) Deucracitinib Anti plaque psoriasis Khamphani ea Bristol-Myers Squibb Nov.07,2033 -
Apremilast
Lebitso la API Pontsho Moqapi Letsatsi la Phello ea Patent(US) Apremilast ramatiki ea psoriatic Celgene -
Remdesivir
Lebitso la API Pontsho Moqapi Letsatsi la Phello ea Patent(US) Remdesivir Li-antivirus (Ebola, Covid-19) Gileade -
Pomalidomide
Lebitso la API Pontsho Moqapi Letsatsi la Phello ea Patent(US) Pomalidomide Moriana oa Oncology Celgene -
Nirmatrelvir
Lebitso la API Pontsho Moqapi Letsatsi la Phello ea Patent(US) Nirmatrelvir 3C-Like Protease (3CLPRO) Inhibitor Le SARS-Cov-2 Mpro Inhibitor -
Eltrombopag
Lebitso la API Pontsho Moqapi Letsatsi la Phello ea Patent(US) Eltrombopag ITP le Aplastic anemia Novartis le GSK Mots'eanong. La 20, 2023 -
Ruxolitinib
Lebitso la API Pontsho Moqapi Letsatsi la Phello ea Patent(US) Ruxolitinib Myelofibrosis Novartis La 6 Phupu 2024 -
Crisaborole
Lebitso la API Pontsho Moqapi Letsatsi la Phello ea Patent(US) Crisaborole Dermatitis ea Atopic le Eczema Pfizer La 11 Phuptjane 2026